# Correction: The Ineffectiveness of Osimertinib in Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Lung Adenocarcinoma With Bone Metastasis: A Case Report

**Authors:** Caitlyn H Livingston, Benjamin Harper, Mathew George

PMC · DOI: 10.7759/cureus.c188 · 2024-08-09

## Full-text entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}
- **Diseases:** Bone Metastasis (MESH:D009362), Lung Adenocarcinoma (MESH:D000077192)
- **Chemicals:** Osimertinib (MESH:C000596361)

---
Source: https://tomesphere.com/paper/PMC11315681